X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with Ruchi Soya Industries - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs RUCHI SOYA INDUSTRIES - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

RUCHI SOYA INDUSTRIES 
   Change

Ruchi Soya, the flagship company of the Ruchi Group, is involved in soya processing, vegetable refined oils, food processing, food supplements, vanaspati, industrial oils, soaps, engineering and fabrication, cooking gas cylinders, cold rolled sheets ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER RUCHI SOYA INDUSTRIES GSK CONSUMER/
RUCHI SOYA INDUSTRIES
 
P/E (TTM) x 34.6 -0.7 - View Chart
P/BV x 9.3 0.6 1,539.0% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 GSK CONSUMER   RUCHI SOYA INDUSTRIES
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
RUCHI SOYA INDUSTRIES
Mar-16
GSK CONSUMER/
RUCHI SOYA INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs6,77146 14,592.0%   
Low Rs5,44821 26,318.8%   
Sales per share (Unadj.) Rs1,024.4906.4 113.0%  
Earnings per share (Unadj.) Rs163.3-28.1 -580.7%  
Cash flow per share (Unadj.) Rs177.0-22.7 -780.6%  
Dividends per share (Unadj.) Rs70.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs581.537.0 1,569.9%  
Shares outstanding (eoy) m42.06334.10 12.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.00 16,112.1%   
Avg P/E ratio x37.4-1.2 -3,135.6%  
P/CF ratio (eoy) x34.5-1.5 -2,332.8%  
Price / Book Value ratio x10.50.9 1,159.9%  
Dividend payout %42.90-   
Avg Mkt Cap Rs m256,95911,209 2,292.4%   
No. of employees `0003.74.3 85.8%   
Total wages/salary Rs m5,0942,270 224.4%   
Avg. sales/employee Rs Th11,548.569,649.4 16.6%   
Avg. wages/employee Rs Th1,365.3522.0 261.5%   
Avg. net profit/employee Rs Th1,841.1-2,160.9 -85.2%   
INCOME DATA
Net Sales Rs m43,087302,836 14.2%  
Other income Rs m2,788743 375.2%   
Total revenues Rs m45,875303,579 15.1%   
Gross profit Rs m8,349-2,536 -329.2%  
Depreciation Rs m5741,821 31.5%   
Interest Rs m86,885 0.1%   
Profit before tax Rs m10,554-10,499 -100.5%   
Minority Interest Rs m0301 0.0%   
Prior Period Items Rs m0-23 0.0%   
Extraordinary Inc (Exp) Rs m024 0.0%   
Tax Rs m3,685-802 -459.6%   
Profit after tax Rs m6,869-9,396 -73.1%  
Gross profit margin %19.4-0.8 -2,313.7%  
Effective tax rate %34.97.6 457.2%   
Net profit margin %15.9-3.1 -513.8%  
BALANCE SHEET DATA
Current assets Rs m37,560117,382 32.0%   
Current liabilities Rs m18,153124,551 14.6%   
Net working cap to sales %45.0-2.4 -1,902.6%  
Current ratio x2.10.9 219.6%  
Inventory Days Days3930 130.5%  
Debtors Days Days3088 33.9%  
Net fixed assets Rs m5,37424,437 22.0%   
Share capital Rs m421688 61.1%   
"Free" reserves Rs m24,0039,521 252.1%   
Net worth Rs m24,45612,374 197.6%   
Long term debt Rs m04,427 0.0%   
Total assets Rs m44,988145,042 31.0%  
Interest coverage x1,336.9-0.5 -254,683.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.02.1 45.9%   
Return on assets %15.3-1.7 -883.1%  
Return on equity %28.1-75.9 -37.0%  
Return on capital %43.2-19.7 -219.1%  
Exports to sales %5.16.6 77.2%   
Imports to sales %0.442.9 0.9%   
Exports (fob) Rs m2,21120,129 11.0%   
Imports (cif) Rs m168129,939 0.1%   
Fx inflow Rs m2,81648,293 5.8%   
Fx outflow Rs m261130,192 0.2%   
Net fx Rs m2,555-81,899 -3.1%   
CASH FLOW
From Operations Rs m5,724-4,613 -124.1%  
From Investments Rs m-1,569-40 3,951.6%  
From Financial Activity Rs m-2,7926,205 -45.0%  
Net Cashflow Rs m1,3631,552 87.8%  

Share Holding

Indian Promoters % 0.0 55.9 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 0.1 800.0%  
FIIs % 12.0 17.2 69.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 26.8 55.2%  
Shareholders   26,457 30,556 86.6%  
Pledged promoter(s) holding % 0.0 15.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   ZYDUS WELLNESS  VENKYS (I) LIMITED  TATA COFFEE  NESTLE  LAKSHMI OVERSEAS IND.  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 18, 2017 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - VENKYS (I) LIMITED COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS